Skip to main content
. Author manuscript; available in PMC: 2019 Dec 14.
Published in final edited form as: Obesity (Silver Spring). 2019 Jun 14;27(8):1266–1274. doi: 10.1002/oby.22525

Table 1.

Participant characteristics at baseline (n=88)

Overall (N = 88) EX only (N = 28) EX+Mod CR (N = 30) EX+High CR (N = 30) P-value
Mean(±SD) Mean(±SD) Mean(±SD) Mean(±SD)
Age (years) 69.0 (3.5) 69.0 (3.7) 68.9 (3.3) 69.0 (3.5) 0.96
Female, N (%) 68 (77.3) 22 (78.6) 23 (76.7) 23 (76.7) 0.98
White, N (%) 56 (63.6) 18 (64.3) 18 (60.0) 20 (66.7) 0.86
Education, N (%) 0.80
< High School 21 (23.9) 8 (28.6) 7 (23.3) 6 (20.0)
High School 46 (52.3) 15 (53.6) 14 (46.7) 17 (56.7)
> High School 21 (23.9) 5 (17.9) 9 (30.0) 7 (23.3)
Weight (kg) 95.3(13.7) 96.6(13.9) 93.9(13.7) 95.7(13.8) 0.81
BMI (kg/m2) 35.3(3.9) 35.2(3.2) 35.7(4.4) 35.0(3.9) 0.87
Percent Body Fat (%) 44.9(5.8) 45.0(5.5) 45.5(6.2) 44.2(5.9) 0.61
Resting Seated Blood
Pressure
SBP (mmHg) 134.0(16.4) 133.3(12.8) 134.5(18.8) 134.2(17.4) 0.85
DBP (mmHg) 73.6(10.2) 74.8(11.1) 73.1(8.9) 72.9(10.6) 0.49
HDL cholesterol (mg/dl) 59.3(15.7) 57.3(13.4) 57.9(13.8) 62.6(19.2) 0.20
LDL cholesterol (mg/dl) 110.1(36.0) 115.6(37.4) 115.0(37.7) 100.0(31.7) 0.09
Triglycerides (mg/dl) 120.2(58.6) 122.7(50.6) 129.3(58.0) 108.9(65.7) 0.36
Fasting Glucose (mg/dl) 102.7(15.3) 104.4(14.9) 100.2(16.6) 103.6(14.5) 0.85
HOMA2-IR 2.1(1.1) 1.9(0.8) 2.3(1.4) 2.1(1.1) 0.66
Self-reported comorbidities, N (%)
Hypertension 57 (64.8) 19 (67.9) 19 (63.3) 19 (63.3) 0.92
Non-insulin treated diabetes 14 (15.9) 6 (21.4) 2 (6.7) 6 (20.0) 0.23
Medication Use, N (%)
Antihypertensive 60 (68.2) 19 (67.9) 22 (73.3) 19 (63.3) 0.71
Antidiabetic 13 (14.8) 5 (17.9) 2 (6.7) 6 (20.0) 0.30
Cholesterol-lowering 38 (43.2) 12 (42.9) 10 (33.3) 16 (53.3) 0.29
Antidepressant/Mood 30 (34.1) 12 (42.9) 9 (30.0) 9 (30.0) 0.50
Peak VO2 (ml/kg/min) 17.6(3.6) 17.7(3.8) 18.0(3.9) 17.2(3.2) 0.62